Tag: Heart Failure
Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction
Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function
Quality Improvement Initiative Ups Adherence to Medical Therapy for Heart Failure
Defect-free quadruple medication therapy significantly improved at discharge, 30 days in patients with heart failure with reduced ejection fraction
Many Heart Failure Patients Do Not See a Cardiologist Annually
Simple stratification based on hospitalization history and diuretic use can predict outcomes for heart failure patients
Heart Failure Tied to Worsening of Neuropsychological Symptoms
Significant cognitive decline, increased depressive symptoms, and reduced self-care reported among those with heart failure
Poor Hearing Associated With Increased Risk for Incident Heart Failure
16.9 percent of the association was mediated by psychological distress; 3.0 and 3.1 percent mediated by social isolation, neuroticism
ACC: Bilateral Oophorectomy Linked to Increased Risk for Heart Failure
Each one-year increase in oophorectomy age linked to 0.6-year delay in onset of heart failure
Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From Meds
Withdrawing renin-angiotensin inhibitors/angiotensin receptor-neprilysin inhibitors and mineralocorticoid receptor antagonists tied to higher one-year mortality, morbidity
ACC: Cannabis Use Linked to Increased Risk for MI in People Aged 50 Years...
Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality
Inpatient Dialysis Initiation Higher for Patients With CKD and Heart Failure
More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction
AI-Assisted Screening Tool Speeds Trial Eligibility Determination
Implementing AI-assisted screening tool enhances clinical trial efficiency, expedites screening process
